Kyowa Hakko U.S.A., Inc. has trademarked its anti-aging Citicoline ingredient under the brand name of Cognizin™. Citicoline has been used in the treatment of neurodegenerative disorders associated with stroke, cerebrovascular pathology, brain aging and head trauma. Scientific studies have indicated effectiveness in treating Alzheimer’s and Parkinson’s disease and improved stroke recuperation, as well as glaucoma.